Kittika Poonsombudlert is a Hematology physician affiliated with University of Iowa Hospitals and Clinics. OpenAlex indexes 50 publications with 282 citations (h-index 8); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Hawkins Dr
Iowa City, IA 522421009
Telephone
319-356-2075Provider last certified this registry record 3 Jul 2024.
Clinical trials
- High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)
Sponsor: Kittika Poonsombudlert
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
61.5%Kinase inhibitor46.7%Jakafi86%Tasigna14%Part D<11 patientsAntimetabolite9.2%Hydroxyurea100%Part D<11 patients+ 1 more class in this area
Dermatology
19%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor19%Acyclovir100%Part D<11 patientsMetabolism & gastrointestinal
7.2%Corticosteroid7.2%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prevalence and Characteristics of CMV Reactivation after Chimeric Antigen Receptor T cell Therapy: A Referral Center Experience
Biology of Blood and Marrow Transplantation
2026 - Effect of <scp><i>NPM1</i></scp> Mutation Subtype and Co‐Mutation Patterns on the Outcomes of Acute Myeloid Leukemia
European Journal Of Haematology
2025 - Real World Outcomes of CAR T-Cell Therapy for B-Cell Lymphoma in Adults Age ≥ 65: A Referral Center Experience
Biology of Blood and Marrow Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Mark Dyken, MD
University of Iowa Hospitals and Clinics
Timothy Ryken, MD
University of Iowa Hospitals and Clinics
Janet Fairley, MD
University of Iowa Hospitals and Clinics
Douglas Labrecque, MD
University of Iowa Hospitals and Clinics
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”